Palmer DH - Search Results

1

Palmer DH, Chen MJ, Kerr DJ. Palmer DH, et al. Br Med Bull. 2002;64:201-25. doi: 10.1093/bmb/64.1.201. Br Med Bull. 2002. PMID: 12421734 Review.

2

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.

Chung-Faye G, Palmer D, Anderson D, Clark J, Downes M, Baddeley J, Hussain S, Murray PI, Searle P, Seymour L, Harris PA, Ferry D, Kerr DJ. Chung-Faye G, et al. Clin Cancer Res. 2001 Sep;7(9):2662-8. Clin Cancer Res. 2001. PMID: 11555577 Clinical Trial.

3

Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.

Milner AE, Palmer DH, Hodgkin EA, Eliopoulos AG, Knox PG, Poole CJ, Kerr DJ, Young LS. Milner AE, et al. Among authors: palmer dh. Cell Death Differ. 2002 Mar;9(3):287-300. doi: 10.1038/sj.cdd.4400945. Cell Death Differ. 2002. PMID: 11859411

4

Clinical experience with adenovirus in cancer therapy.

Palmer DH, Mautner V, Kerr DJ. Palmer DH, et al. Curr Opin Mol Ther. 2002 Oct;4(5):423-34. Curr Opin Mol Ther. 2002. PMID: 12435043 Review.

5

Taking Gene Therapy into the Clinic.

Palmer DH, Chen MJ, Kerr DJ. Palmer DH, et al. J Biomed Biotechnol. 2003;2003(1):71-77. doi: 10.1155/S111072430320913X. J Biomed Biotechnol. 2003. PMID: 12686723 Free PMC article.

6

Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil.

Palmer DH, Milner AE, Kerr DJ, Young LS. Palmer DH, et al. Br J Cancer. 2003 Sep 1;89(5):944-50. doi: 10.1038/sj.bjc.6601211. Br J Cancer. 2003. PMID: 12942130 Free PMC article.

7

Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.

Palmer DH, Mautner V, Mirza D, Oliff S, Gerritsen W, van der Sijp JR, Hubscher S, Reynolds G, Bonney S, Rajaratnam R, Hull D, Horne M, Ellis J, Mountain A, Hill S, Harris PA, Searle PF, Young LS, James ND, Kerr DJ. Palmer DH, et al. J Clin Oncol. 2004 May 1;22(9):1546-52. doi: 10.1200/JCO.2004.10.005. Epub 2004 Mar 29. J Clin Oncol. 2004. PMID: 15051757 Clinical Trial.

8

Endocrine therapy and other targeted therapies for metastatic breast cancer.

Hussain SA, Palmer DH, Moon S, Rea DW. Hussain SA, et al. Among authors: palmer dh. Expert Rev Anticancer Ther. 2004 Dec;4(6):1179-95. doi: 10.1586/14737140.4.6.1179. Expert Rev Anticancer Ther. 2004. PMID: 15606341 Review.

9

Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.

Palmer DH, Chen MJ, Searle PF, Kerr DJ, Young LS. Palmer DH, et al. Gene Ther. 2005 Aug;12(15):1187-97. doi: 10.1038/sj.gt.3302510. Gene Ther. 2005. PMID: 15800660

10

Gene- and immunotherapy for hepatocellular carcinoma.

Palmer DH, Hussain SA, Johnson PJ. Palmer DH, et al. Expert Opin Biol Ther. 2005 Apr;5(4):507-23. doi: 10.1517/14712598.5.4.507. Expert Opin Biol Ther. 2005. PMID: 15934829 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters